NLRP9
Basic information
Region (hg38): 19:55708438-55738402
Previous symbols: [ "NALP9" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 3 of 3.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_176820.4 | NP_789790.2 | 9 | yes | - |
ENST00000332836.7 | ENSP00000331857.2 | 9 | yes | - |
ENST00000590200.1 | ENSP00000465253.1 | 9 | - | - |
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (155 variants)
- not_provided (20 variants)
- Congenital_stationary_night_blindness (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRP9 gene is commonly pathogenic or not. These statistics are base on transcript: NM_176820.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 5 | 11 | ||
| missense | 144 | 15 | 3 | 162 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 146 | 20 | 8 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NLRP9 | protein_coding | protein_coding | ENST00000332836 | 9 | 29971 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125314 | 2 | 432 | 125748 | 0.00173 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.643 | 564 | 523 | 1.08 | 0.0000269 | 6555 |
| Missense in Polyphen | 114 | 120.71 | 0.94437 | 1771 | ||
| Synonymous | -1.66 | 244 | 213 | 1.14 | 0.0000125 | 1845 |
| Loss of Function | 0.0291 | 37 | 37.2 | 0.995 | 0.00000191 | 492 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00390 | 0.00382 |
| Ashkenazi Jewish | 0.00233 | 0.00228 |
| East Asian | 0.00439 | 0.00430 |
| Finnish | 0.0000473 | 0.0000462 |
| European (Non-Finnish) | 0.00124 | 0.00123 |
| Middle Eastern | 0.00439 | 0.00430 |
| South Asian | 0.00316 | 0.00304 |
| Other | 0.00116 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: As the sensor component of the NLRP9 inflammasome, plays a crucial role in innate immunity and inflammation. In response to pathogens, including rotavirus, initiates the formation of the inflammasome polymeric complex, made of NLRP9, PYCARD and CASP1. Recruitment of proCASP1 to the inflammasome promotes its activation and CASP1-catalyzed IL1B and IL18 maturation and release in the extracellular milieu. The active cytokines stimulate inflammatory responses. Inflammasomes can also induce pyroptosis, an inflammatory form of programmed cell death. NLRP9 inflammasome activation may be initiated by DHX9 interaction with viral double-stranded RNA (dsRNA), preferentially to short dsRNA segments. {ECO:0000269|PubMed:28636595}.;
Recessive Scores
- pRec
- 0.0823
Intolerance Scores
- loftool
- 0.693
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 45.68
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0987
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- inflammatory response;positive regulation of interleukin-18 production;innate immune response;defense response to virus;pyroptosis
- Cellular component
- inflammasome complex
- Molecular function
- protein binding;ATP binding